Business Development

Researchers in the National Drug Discovery Centre

WEHI has a strong track record in early capture of intellectual property and commercialisation.

Through our established partnerships with pharmaceutical or biotech companies we are developing novel therapies that could be effective in treating certain cancers, immune disorders and infectious diseases as well as developmental and neurodegenerative diseases.

Partnerships and collaborations

	Advancing drug discovery through skill sharing
	Paving the way for new inflammatory disease therapeutics
	Developing new cancer immunotherapies
	Targeting MCL-1, cancer’s Achilles heel
	Necroptosis research leads to spin-out company
	Developing targeted protein degraders into innovative cancer medicine s

Outcomes

30 projects commercialised by WEHI and under development with partners
18 proprietary projects under discussions with potential industry partners and investors
Active management of 11 strategic alliances
Development and management of more than 500 agreements executed every year with local and international partners
45 WEHI-originated patent families actively maintained; 17 patents successfully licensed to third parties

Partnered projects

Licensing and co-development partnerships

WEHI research teams focus on solving complex biological questions and linking laboratory results to clinical outcomes. The Business Development Office is always seeking partnerships to push our drug discovery and development programs forward.

Current partnering opportunities

Start-up companies

The Business Development Office also supports the development of start-up companies created based on intellectual property developed within WEHI.

WEHI’s start-up companies